353 related articles for article (PubMed ID: 28317138)
1. Impact of providing psychiatry specialty pharmacist intervention on reducing drug-related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open-label study.
Wongpakaran R; Suansanae T; Tan-Khum T; Kraivichian C; Ongarjsakulman R; Suthisisang C
J Clin Pharm Ther; 2017 Jun; 42(3):329-336. PubMed ID: 28317138
[TBL] [Abstract][Full Text] [Related]
2. Handling drug-related problems in rehabilitation patients: a randomized study.
Willoch K; Blix HS; Pedersen-Bjergaard AM; Eek AK; Reikvam A
Int J Clin Pharm; 2012 Apr; 34(2):382-8. PubMed ID: 22388601
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of drug-related problems among hospitalized ischemic stroke patients in China.
Chen Q; Jin Z; Zhang P; Sun S; Li L; Liao Y
Int J Clin Pharm; 2020 Aug; 42(4):1237-1241. PubMed ID: 32607718
[TBL] [Abstract][Full Text] [Related]
4. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
[TBL] [Abstract][Full Text] [Related]
5. Management of pharmacotherapy-related problems in acute coronary syndrome: Role of clinical pharmacist in cardiac rehabilitation unit.
Casper EA; El Wakeel LM; Saleh MA; El-Hamamsy MH
Basic Clin Pharmacol Toxicol; 2019 Jul; 125(1):44-53. PubMed ID: 30739389
[TBL] [Abstract][Full Text] [Related]
6. Identification of drug-related problems followed by clinical pharmacist interventions in an outpatient pharmacotherapy clinic.
Shahrami B; Sefidani Forough A; Najmeddin F; Hadidi E; Toomaj S; Javadi MR; Gholami K; Sadeghi K
J Clin Pharm Ther; 2022 Jul; 47(7):964-972. PubMed ID: 35218217
[TBL] [Abstract][Full Text] [Related]
7. Identification of drug-related problems by a clinical pharmacist in addition to computerized alerts.
Zaal RJ; Jansen MM; Duisenberg-van Essenberg M; Tijssen CC; Roukema JA; van den Bemt PM
Int J Clin Pharm; 2013 Oct; 35(5):753-62. PubMed ID: 23715760
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
[TBL] [Abstract][Full Text] [Related]
9. In-hospital medication reviews reduce unidentified drug-related problems.
Bondesson A; Eriksson T; Kragh A; Holmdahl L; Midlöv P; Höglund P
Eur J Clin Pharmacol; 2013 Mar; 69(3):647-55. PubMed ID: 22955893
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients: A pre-experimental prospective study at a general hospital in Indonesia.
Sagita VA; Bahtiar A; Andrajati R
Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e81-e87. PubMed ID: 29666686
[TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacists' interventions on the pharmacotherapy of patients with complex needs monitored in multidisciplinary primary care teams.
Samir Abdin M; Grenier-Gosselin L; Guénette L
Int J Pharm Pract; 2020 Feb; 28(1):75-83. PubMed ID: 31468599
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams.
Blix HS; Viktil KK; Moger TA; Reikvam A
Pharm World Sci; 2006 Jun; 28(3):152-8. PubMed ID: 17004023
[TBL] [Abstract][Full Text] [Related]
13. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
14. Collaboration between hospital and community pharmacists to address drug-related problems: The HomeCoMe-program.
Ensing HT; Koster ES; Dubero DJ; van Dooren AA; Bouvy ML
Res Social Adm Pharm; 2019 Mar; 15(3):267-278. PubMed ID: 29773308
[TBL] [Abstract][Full Text] [Related]
15. Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial.
AbuRuz S; Jaber D; Basheti I; Sadeq A; Arafat M; AlAhmad M; Said A
Eur J Hosp Pharm; 2021 Nov; 28(Suppl 2):e72-e78. PubMed ID: 32661104
[TBL] [Abstract][Full Text] [Related]
16. Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients.
Covert KL; Mardis CR; Fleming JN; Pilch NA; Meadows HB; Mardis BA; Mohan P; Posadas-Salas M; Srinivas T; Taber DJ
Pharmacotherapy; 2017 Feb; 37(2):159-169. PubMed ID: 27997676
[TBL] [Abstract][Full Text] [Related]
17. Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing.
Raimbault-Chupin M; Spiesser-Robelet L; Guir V; Annweiler C; Beauchet O; Clerc MA; Moal F
Int J Clin Pharm; 2013 Oct; 35(5):847-53. PubMed ID: 23857430
[TBL] [Abstract][Full Text] [Related]
18. A multicenter quality improvement initiative on the impact of pharmacists' postdischarge follow-up to reduce medication-related acute care episodes.
Noh L; Heimerl K; Shane R
Am J Health Syst Pharm; 2020 Jun; 77(12):938-942. PubMed ID: 31960043
[TBL] [Abstract][Full Text] [Related]
19. Acceptability of pharmacist-led interventions to resolve drug-related problems in patients with chronic myeloid leukaemia.
Tan BK; Chua SS; Chen LC; Chang KM; Balashanker S; Bee PC
J Oncol Pharm Pract; 2021 Oct; 27(7):1644-1656. PubMed ID: 33040675
[TBL] [Abstract][Full Text] [Related]
20. Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use.
Al-Hashar A; Al-Zakwani I; Eriksson T; Sarakbi A; Al-Zadjali B; Al Mubaihsi S; Al Za'abi M
Int J Clin Pharm; 2018 Oct; 40(5):1154-1164. PubMed ID: 29754251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
